Literature DB >> 15734648

TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.

Sophie Vanwetswinkel1, Robert J Heetebrij, John van Duynhoven, Johan G Hollander, Dmitri V Filippov, Philip J Hajduk, Gregg Siegal.   

Abstract

We propose a ligand screening method, called TINS (target immobilized NMR screening), which reduces the amount of target required for the fragment-based approach to drug discovery. Binding is detected by comparing 1D NMR spectra of compound mixtures in the presence of a target immobilized on a solid support to a control sample. The method has been validated by the detection of a variety of ligands for protein and nucleic acid targets (K(D) from 60 to 5000 muM). The ligand binding capacity of a protein was undiminished after 2000 different compounds had been applied, indicating the potential to apply the assay for screening typical fragment libraries. TINS can be used in competition mode, allowing rapid characterization of the ligand binding site. TINS may allow screening of targets that are difficult to produce or that are insoluble, such as membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734648     DOI: 10.1016/j.chembiol.2004.12.004

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  26 in total

1.  Screening a fragment cocktail library using ultrafiltration.

Authors:  Sayaka Shibata; Zhongsheng Zhang; Konstantin V Korotkov; Jaclyn Delarosa; Alberto Napuli; Angela M Kelley; Natasha Mueller; Jennifer Ross; Frank H Zucker; Frederick S Buckner; Ethan A Merritt; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Erkang Fan
Journal:  Anal Bioanal Chem       Date:  2011-07-13       Impact factor: 4.142

2.  Fragment-based drug discovery.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2009-06-24       Impact factor: 3.686

Review 3.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

4.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

Review 5.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 6.  The role of small-angle scattering in structure-based screening applications.

Authors:  Po-Chia Chen; Janosch Hennig
Journal:  Biophys Rev       Date:  2018-10-10

7.  Labeled Ligand Displacement: Extending NMR-Based Screening of Protein Targets.

Authors:  Steven L Swann; Danying Song; Chaohong Sun; Philip J Hajduk; Andrew M Petros
Journal:  ACS Med Chem Lett       Date:  2010-06-24       Impact factor: 4.345

Review 8.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 9.  Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy.

Authors:  Guillaume Ferré; Matthew T Eddy
Journal:  Methods       Date:  2020-09-08       Impact factor: 3.608

Review 10.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.